Literature DB >> 27660790

Identification and Whole-Genome Sequencing of Four Enterovirus D68 Strains in Southern China in Late 2015.

Long Chen1, Lei Shi2, Hong Yang1, Da-Yong Gu2, Jun Meng1, Yun-Qing Xu2, Xiang-Jie Yao1, Hai-Long Zhang1, Jin-Quan Cheng1, Han-Wu Ma1, Ren-Li Zhang3, Ya-Qing He3.   

Abstract

Four enterovirus D68 (EV-D68) strains from four children with influenza-like illness were identified in Shenzhen, southern China, in late 2015. Here, we announce the availability of these viral genomes in GenBank. The genomic sequences of these EV-D68 strains showed the closest phylogenetic relationship to strains from northern China.
Copyright © 2016 Chen et al.

Entities:  

Year:  2016        PMID: 27660790      PMCID: PMC5034141          DOI: 10.1128/genomeA.01014-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Enterovirus D68 (EV-D68), a member of the enterovirus D species of the family Picornaviridae, is a single stranded, positive-sense RNA virus with an ~7.3-kb genome (1, 2). Its genome comprises a 5′ untranslated region (5′-UTR), structural polypeptide P1, nonstructural polypeptides P2 and P3, and a 3′ untranslated region (3′-UTR). P1, P2, and P3 are cleaved into four structural proteins (VP1 to VP4), three nonstructural proteins (2A to 2C), and four nonstructural proteins (3A to 3D), respectively. EV-D68 was originally isolated from four American children with respiratory illness in 1962 (3). Since then, EV-D68 had not caused public concern until its outbreaks in the United States in the second half of 2014 (4–7). Subsequently, some retrospective and field epidemiological investigations on the prevalence of EV-D68 associated with respiratory infections were successively reported in different geographic regions (8–10). These data have demonstrated an increasing number of patients with EV-D68 infections and the wide spread of EV-D68 across the world in recent years. Between 16 November 2015 and 16 December 2015, four EV-D68 strains from four children with influenza-like illness were identified by real-time reverse transcription PCR and sequencing of VP1 genes in Shenzhen, southern China (11). Next, two sets of primers pairs, EVD68-1F21 (TTAAAACAGCTCTGGGGTTGT)/EVD68-4570R27 (ATTTTGCATTAAATCATCCATAAGGAC) and EVD68-4394F26 (TCAAGTCCAAATCTCGCATTGAACCG)/EVD68-7340R27 (GTCCCCAAGTGACCAAAATTTACCTCT), were designed to amplify two overlapping fragments encompassing the complete genome of EV-D68. Amplified DNA products were sequenced by TaKaRa using a primer-walking method. The two overlapping fragments were assembled into a complete genome using Lasergene version 7.1. The assembled genome sequences were examined using BioEdit version 7.2.5 before submission to GenBank. The complete genome sequences of the four EV-D68 strains from the study were composed of 7,293 nucleotides (nt), excluding the poly(A) tail. The 5′-UTR contains 699 nt, followed by an open reading frame encoding the structural protein P1 (2,583 nt), the nonstructural proteins P2 (1,728 nt) and P3 (2,253 nt), and the 3′-UTR (27 nt). The base compositions of the full genomes of the four EV-D68 strains are 31.58 to 31.67% A, 20.35 to 20.47% C, 21.34 to 21.42% G, and 26.53 to 26.64% U. The complete nucleotide sequences and complete amino acid sequences (2,188 aa) of the four EV-D68 strains showed 0 to 2.9% and 0 to 0.8% differences to each other, respectively. No sequence insertion or deletion was observed in the complete genome region of the four EV-D68 strains compared to the closest known strains. Genome-wide sequence analysis indicated that these four EV-D68 strains belonged to the latest clade comprising some sporadic strains from China. Recent EV-D68 strains have evolved worldwide into distinct clades, which shows the trend of further geographical spread (6, 12–18). Since there is no epidemiological data on EV-D68 infections in southern China at present, this study urges us to investigate the prevalence of EV-D68 as quickly as possible and strengthen surveillance of EV-D68 to prevent its outbreak.

Accession number(s).

The complete genome sequences of four EV-D68 strains from the present study have been deposited in GenBank under the accession numbers KU982558 to KU982561.
  18 in total

1.  Molecular epidemiology of enterovirus D68 from 2013 to 2014 in Philippines.

Authors:  Yuki Furuse; Natthawan Chaimongkol; Michiko Okamoto; Tadatsugu Imamura; Mariko Saito; Raita Tamaki; Mayuko Saito; Socorro P Lupisan; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

2.  A probable new human picornavirus associated with respiratory diseases.

Authors:  J H Schieble; V L Fox; E H Lennette
Journal:  Am J Epidemiol       Date:  1967-03       Impact factor: 4.897

3.  Enterovirus 94, a proposed new serotype in human enterovirus species D.

Authors:  Teemu P Smura; Nina Junttila; Soile Blomqvist; Helene Norder; Svetlana Kaijalainen; Anja Paananen; Lars O Magnius; Tapani Hovi; Merja Roivainen
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

Review 4.  Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak.

Authors:  Christopher M Oermann; Jennifer E Schuster; Gregory P Conners; Jason G Newland; Rangaraj Selvarangan; Mary Anne Jackson
Journal:  Ann Am Thorac Soc       Date:  2015-05

5.  Enterovirus D68 disease and molecular epidemiology in Australia.

Authors:  Avram Levy; Jason Roberts; Jurissa Lang; Simone Tempone; Alison Kesson; Alfred Dofai; Andrew J Daley; Bruce Thorley; David J Speers
Journal:  J Clin Virol       Date:  2015-06-17       Impact factor: 3.168

6.  Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses.

Authors:  M Steven Oberste; Kaija Maher; David Schnurr; Mary R Flemister; Judith C Lovchik; Heather Peters; Wendy Sessions; Carol Kirk; Nando Chatterjee; Susan Fuller; J Michael Hanauer; Mark A Pallansch
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

7.  Enterovirus D-68: an emerging cause of infection.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Expert Rev Respir Med       Date:  2015-11-04       Impact factor: 3.772

8.  Outbreaks of enterovirus D68 in Malaysia: genetic relatedness to the recent US outbreak strains.

Authors:  Kim Tien Ng; Xiang Yong Oong; Yong Kek Pang; Nik Sherina Hanafi; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  Emerg Microbes Infect       Date:  2015-08-05       Impact factor: 7.163

9.  Enterovirus D68-associated acute respiratory distress syndrome in adult, United States, 2014.

Authors:  John J Farrell; Ossama Ikladios; Kristine M Wylie; Lindsay M O'Rourke; Kristin S Lowery; Jenna S Cromwell; Todd N Wylie; Elsa L Vazquez Melendez; Yves Makhoul; Rangarajan Sampath; Robert A Bonomo; Gregory A Storch
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

10.  Prevalence and molecular characterizations of enterovirus D68 among children with acute respiratory infection in China between 2012 and 2014.

Authors:  Qiuyan Xiao; Luo Ren; Shouyan Zheng; Lili Wang; Xiaohong Xie; Yu Deng; Yao Zhao; Xiaodong Zhao; Zhengxiu Luo; Zhou Fu; Ailong Huang; Enmei Liu
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

View more
  3 in total

1.  Upsurge of Enterovirus D68 and Circulation of the New Subclade D3 and Subclade B3 in Beijing, China, 2016.

Authors:  Lingyu Shen; Cheng Gong; Zichun Xiang; Tiegang Zhang; Maozhong Li; Aihua Li; Ming Luo; Fang Huang
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

2.  Molecular epidemiological study of enterovirus D68 in hospitalised children in Hong Kong in 2014-2015 and their complete coding sequences.

Authors:  Haichao Wang; Kinpong Tao; Cheuk Yin Leung; Kam Lun Hon; C M Apple Yeung; Zigui Chen; K S Paul Chan; Ting-Fan Leung; W Y Renee Chan
Journal:  BMJ Open Respir Res       Date:  2019-07-01

3.  Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy.

Authors:  Antonio Piralla; Nicola Principi; Luca Ruggiero; Alessia Girello; Federica Giardina; Elisabetta De Sando; Silvia Caimmi; Sonia Bianchini; Gian Luigi Marseglia; Giovanna Lunghi; Fausto Baldanti; Susanna Esposito
Journal:  J Clin Virol       Date:  2018-01-12       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.